SEC Filing Details

Document Details

Form
Filing Date
Aug 3, 2017
Document Date
Jul 31, 2017
Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group
3,4,5
Company
Theravance Biopharma, Inc.
Issuer
Theravance Biopharma, Inc.